Cours BioSig Technologies Inc Other OTC
Actions
US09073N1028
Equipement et technologie médicale avancés
CA 2024 * | 100 k 91,15 k | CA 2025 * | 1 M 912 k | Capitalisation | 15,34 M 13,98 M |
---|---|---|---|---|---|
Résultat net 2024 * | -6 M -5,47 M | Résultat net 2025 * | -12 M -10,94 M | VE / CA 2024 * | 153 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 15,3 x |
PER 2024 * |
-1,83
x | PER 2025 * |
-1,05
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 81,19% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Frederick Hrkac
CEO | Chief Executive Officer | 58 | 27/02 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 24/02/09 |
Chief Tech/Sci/R&D Officer | 74 | 24/02/09 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 24/02/09 | |
Frederick Hrkac
CEO | Chief Executive Officer | 58 | 27/02 |
Varia. 1 janv. | Capi. | |
---|---|---|
+8,07% | 219 Md | |
+6,59% | 183 Md | |
+11,26% | 133 Md | |
+26,57% | 108 Md | |
+2,05% | 63,06 Md | |
+13,35% | 52,02 Md | |
-0,62% | 48,2 Md | |
-0,93% | 40,37 Md | |
+11,54% | 39,35 Md |